Table 1.
Characteristics | Frequency (%) or Median (IQR) |
---|---|
Gender | |
Male | 61 (52%) |
Female | 56 (48%) |
BMI | Mean 24.4 (IQR 22.2–27.6) |
Disease | |
AML | 34 (29%) |
NHL | 39 (33%) |
HL | 20 (17%) |
MM | 13 (11%) |
Others | 11 (10%) |
Therapy | |
Allogeneic Tx | 12 (10%) |
Autologous Tx | 56 (48%) |
Chemotherapy | 49 (42%) |
Positive cultures bacterial cultures | |
Blood | 34 (29%) |
Stool | 9 (7%) |
Both | 2 (2%) |
Involved sites | |
Small bowel | 20 (17%) |
Colon | 70 (60%) |
Both | 27 (23%) |
BWT | |
≤10 mm | 88 (75%) |
>10 mm | 29 (25%) |
Abbreviations: BMI: body mass index; AML: acute myeloid leukemia; NHL: non-Hodgkin lymphoma; HL: Hodgkin’ lymphoma; MM: multiple myeloma; Tx: transplant; BWT: bowel wall thickness.